Last year, a number of new records were set, and today, we take a look at some of the top trading trends from 2024. Markets rallied to new all-time highs. As interest rates fell,

We are committed to providing an accessible digital experience for all users by working to achieve conformance under Web Content Accessibility Guidelines (WCAG) 2.2 Level AA. To accomplish this goal,

Written by Nikolaus Hoffman for Bitcoin Magazine ->

About This EventTSS, Inc. (Nasdaq: TSSI), a leader in IT hardware and software integration for AI and high-performance computing, visits the Nasdaq MarketSite in Times Square, celebrating its recent uplisting.

This article looks at three stocks with solid insider and institutional buying in Q4 2024 and determines whether they are suitable for 2025.  B&G Foods: High-Yielding Consumer Staple Has Risks B&G Foods (NYSE: BGS) is a small-cap consumer staple with an extensive portfolio of brands.

For the full fiscal 2024, its adjusted EPS is expected to surge by a notable 184.8% year-over-year to $4.13. While in fiscal 2025, its earnings are expected to increase 27.6% year-over-year to $5.27 per share.

At issue is the Tax Cuts and Jobs Act of 2017, which was a hallmark of Trump’s first term. Abbreviated TCJA, the law made sweeping changes to the U.S. tax code that slashed the average person’s income taxes by about $1,600 in 2018 (but benefited wealthy households the most).

The transportation average has trended higher for the last two years and is set to reach new highs this year. The price action in early 2025 is bullish, confirming the trend with a strong signal, including crossovers in critical moving averages. While not technically a Golden Crossover, the set confirms the trend with a strong signal.

The global financial system has reached unprecedented levels of complexity, but banks now have better tools available to tackle these challenges head-on. A new report released today, January 22, from Nasdaq and Boston Consulting Group (BCG),

Institutional buyers from Geode Capital Management decided to boost their holdings in Xometry stock by 4.3% as of November 2024, bringing their net position to a high of $18.3 million today. They were followed by Barclays and Franklin Resources shortly after, who accumulated a stake of $1.3 million and $731,000.

Stock buybacks often drive up share prices. By reducing the supply of shares in the market, buybacks can create upward pressure on stock prices, benefiting shareholders who see an increase in the value of their investments. This effect is particularly pronounced when buybacks occur during periods of undervaluation.

Sana is a gene and cell therapy clinical-stage biotech firm and a penny stock that has fallen by 48.5% in the year leading to January 17, 2025. What may set this company apart from a host of similar penny stock biotechs, however, is its investigational allogeneic cell therapy being studied in type 1 diabetes.